NCT00131989
- Conditions
- Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), +37 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
Clinical trial condition
Congenital Abnormalities
Explore clinical trials studying Congenital Abnormalities. Study availability and eligibility vary by location and protocol.
577 public trials
53 recruiting studies
Congenital Abnormalities trial results
Completed
Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT00112853
- Conditions
- Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +27 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
NCT00012376
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +46 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
NCT00357708
- Conditions
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +33 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00027560
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +54 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00005622
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +56 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
NCT00296023
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +64 more
- Locations
-
- Alta Bates Comprehensive Cancer Center Berkeley, California, United States
- UCSF Comprehensive Cancer Center San Francisco, California, United States
NCT00787761
- Conditions
- Adenocarcinoma, Blast Crisis, Blood Protein Disorders, +82 more
- Locations
-
- Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
Completed
A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide
NCT00005793
- Conditions
- Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT00110045
- Conditions
- Adnexal Diseases, Amyloidosis, Ataxia, +137 more
- Locations
-
- CHU Liege - Domaine Universitaire du Sart Tilman Liège, Belgium
- Centre Hospitalier Universitaire Henri Mondor Créteil, France
- Hopital Edouard Herriot - Lyon Lyon, France
- Hopital Saint-Louis Paris, France